0000000000671607

AUTHOR

Socrates J. Tzartos

showing 5 related works from this author

Expression of the Acetylcholine Receptor α-Subunit Gene is Associated with Paraneoplastic Myasthenia Gravis in Mixed Thymoma

2000

Myasthenia gravis (MG) is an autoimmune disease caused by autoantibodies against the acetylcholine receptor (AChR) at the neuromuscular junction [1]. The muscular AChR has been extensively characterized [2], but the etiology of MG is still obscure. Whether the muscular AChR or another (auto)antigen plays a role during the initiation of MG is unknown [3]. The muscular AChR is a pentameric ion channel composed of four different subunits. The α-subunit contains the acetylcholine binding site and the main epitopes recognized by MG autoantibodies [2]. The human muscle AChR α-subunit exists as two isoforms, P3A- and P3A+ [4]. This is a result of alternative splicing of the P3A exon located betwee…

Gene isoformanimal structuresChemistryAlternative splicingmusculoskeletal systemmedicine.diseasemedicine.disease_causeMolecular biologyNeuromuscular junctionMyasthenia gravisAcetylcholine bindingMolecular mimicrymedicine.anatomical_structureNicotinic agonistmedicinetissuesAcetylcholine receptor
researchProduct

Neurofilament is an autoantigenic determinant in myasthenia gravis

1999

Intratumorous expression of a 153-kd protein (p153), which contains an acetylcholine receptor-like epitope, is the only tumor marker described to date that significantly associates with thymoma in paraneoplastic myasthenia gravis (MG). Here, we report that p153 is identical to the midsize neurofilament, as verified by immunohistochemistry, immunofluorescence, and western blot analysis. Furthermore, the acetylcholine receptor-like epitope of the midsize neurofilament (NF-M) was identified by peptide epitope mapping. We also show, using T-cell proliferation assays, a significantly increased response of intratumorous T cells to a recombinant midsize neurofilament fragment in thymoma patients w…

Pathologymedicine.medical_specialtyThymomamusic.instrumentNeurofilamentmedicine.diagnostic_testBiologymedicine.diseaseImmunofluorescenceFollicular hyperplasiaMyasthenia gravisEpitopeNeurologyhemic and lymphatic diseasesmedicineImmunohistochemistryNeurology (clinical)musicAcetylcholine receptorAnnals of Neurology
researchProduct

Low Levels of Acetylcholine Receptor Delta-Subunit Message and Protein in Human Thymus Suggests the Occurrence of ‘Triplet Receptors’ in Thymic Myoid…

2000

Myasthenia gravis (MG) is an autoimmune disease caused by autoantibodies against the acetylcholine receptor (AChR) at the neuromuscular junction [1]. The muscular AChR has been extensively characterized [2], but whether the muscular AChR plays a role during the initiation of MG is unknown [3]. The muscular AChR is a pentameric ion channel composed of 4 different subunits [2, 4]. The fetal AChR expressed during intrauterine life and after denervation of adult muscle exhibits an α2βδγ composition, while the adult AChR expressed after birth in innervated muscle exhibits an α2βδγ composition [4]. The α-subunit contains the main epitopes recognized by MG autoantibodies [2]. The human muscle AChR…

DenervationGene isoformmedicine.medical_specialtyanimal structuresThymomaBiologymusculoskeletal systemmedicine.diseaseMolecular biologyEpitopeMyasthenia gravisNeuromuscular junctionEndocrinologymedicine.anatomical_structureInternal medicinemedicineReceptortissuesAcetylcholine receptor
researchProduct

Severe congenital myasthenic syndrome due to homozygosity of the 1293insG ε-acetylcholine receptor subunit mutation

2000

Recently, a congenital myasthenic syndrome (CMS) with end-plate acetylcholine receptor (AChR) deficiency due to missense mutations in the genes for the AChR subunit was described. The first observed patient with this CMS was heteroallelic for the two epsilon-AChR subunit mutations epsilon1101insT and epsilon1293insG. This patient had only a moderate phenotype with mild muscle weakness and abnormal fatigue. We have now found homozygosity for the epsilon1293insG mutation in a severely affected CMS patient, who lost the ability to walk in midchildhood and shows profound weakness and muscle wasting. Our observation allows a genotype-phenotype correlation illustrating how differences in the AChR…

MutationWeaknessmedicine.medical_specialtyNonsense mutationHaplotypeBiologyCongenital myasthenic syndromemedicine.disease_causemedicine.diseaseMyasthenia gravisEndocrinologyNeurologyInternal medicineImmunologymedicineMissense mutationNeurology (clinical)medicine.symptomAcetylcholine receptorAnnals of Neurology
researchProduct

Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor

2014

Myasthenia gravis (MG) with antibodies against the acetylcholine receptor (AChR-MG) is considered as a prototypic autoimmune disease. The thymus is important in the pathophysiology of the disease since thymus hyperplasia is a characteristic of early-onset AChR-MG and patients often improve after thymectomy. We hypothesized that thymic B cell and antibody repertoires of AChR-MG patients differ intrinsically from those of control individuals. Using immortalization with Epstein Barr Virus and Toll-like receptor 9 activation, we isolated and characterized monoclonal B cell lines from 5 MG patients and 8 controls. Only 2 of 570 immortalized B cell clones from MG patients produced antibodies agai…

AdultHerpesvirus 4 Human[SDV]Life Sciences [q-bio]medicine.medical_treatmentImmunologyThymus GlandBiologyYoung AdultAntigenmedicineImmunology and AllergyHumansReceptors CholinergicMyasthenia gravisComputingMilieux_MISCELLANEOUSB cellAutoantibodiesCell Line TransformedAutoimmune diseaseB-LymphocytesB-cell immortalizationHyperplasiaStriational autoantibodiesSingle-Domain Antibodiesmedicine.diseaseCell Transformation ViralMyasthenia gravisMuscle StriatedClonal expansion3. Good healthClone CellsThymectomymedicine.anatomical_structurePolyclonal antibodiesToll-Like Receptor 9ImmunologyMutationbiology.proteinFemaleThymus hyperplasiaAntibodyJournal of Autoimmunity
researchProduct